Although there was no evidence for enhanced loss of motor neurons in a SOD mutant mouse model following genetic ablation of Kir4.1, this study suggests that the initial clinical presentation of weakness in ALS may be related to astrocyte-specific down-regulation of Kir4.1. Here, SOD1 is linked to amyotrophic lateral sclerosis.